Physicians’ Opinions Survey on FDA’s Bydureon Approval

Report Description

Physicians were asked to assess their impressions of Bydureon in terms of efficacy, safety, tolerability, expected use, and other important factors. Key questions are broken down by specialty or familiarity to highlight difference in physician perceptions

Highlights

Datamonitor anticipates that the initial enthusiasm will ultimately be muted once physicians gain experience with the drug. Nevertheless, a once-weekly antidiabetic agent clearly represents an attractive option for type 2 diabetes patients, and physicians expect the drug to be a welcome addition to their armamentarium.

FDA’s Bydureon Approval

Published: February 2012
Price
: Single User License US$3800            Corporate User License – US$9500

                    Request Sample


Your key questions answered
  • Assess physicians’ opinions of Bydureon as compared with Amylin’s twice-daily Byetta (exenatide) and Novo Nordisk’s once-daily Victoza (liraglutide)
  • Determine physicians’ expectations for Bydureon’s uptake, line of therapy, and use in combination with other antidiabetics
  • Evaluate how Bydureon may expand the overall market for GLP-1 agonists

Table of Contents

BYDUREON FDA APPROVAL: PHYSICIAN OPINION
Background

SURVEY RESULTS
Demographics
Limited familiarity with PCPs could present a marketing challenge
Impressions of Bydureon’s efficacy differ based on familiarity
Tolerability issues trump safety concerns among physicians familiar with Bydureon
High expectations for Bydureon use will likely come down with increased experience
Endocrinologists expect to use Bydureon in earlier line of therapy compared to PCPs
Combination use with oral antidiabetics is likely
Physicians expect Bydureon to expand the GLP-1 agonist market
Conclusion

APPENDIX
Report methodology
Datamonitor consulting

Disclaimer

List of Figures

Figure: On average, how many patients with type 2 diabetes do you treat per month?
Figure: How familiar are you with Bydureon (once-weekly exenatide)?
Figure: For each attribute below, please select the one drug that you would prefer to prescribe, based on performance (or predicted performance) on that attribute
Figure: Please select the one drug that you would prefer to prescribe, based on efficacy (HbA1c lowering ability)
Figure: Please rank the following potential safety (and tolerability) issues you are most concerned about with Bydureon on a scale of 1 to 7, where 1 is the issue of greatest concern and 7 is the issue of least concern
Figure: Please select the one drug that you would prefer to prescribe, based on injection device
Figure: Where in the treatment algorithm do you think you will most commonly prescribe Bydureon?
Figure: Please consider your hypothetical Bydureon-treated patient population a year post-launch. What percentage of the Bydureon-treated patient population do you expect to have previously been treated with each of the following options?
Figure: Please choose up to three drug classes with which Bydureon could be used in combination. If there are more than three classes, please select the three most likely
Figure: Please give your opinion on how the introduction of Bydureon, and any other market trends, will impact on the number of patients on GLP-1 agonists in the US

Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
More Reports
Title Price Buy Now

Global Air Ambulance Market 2015-2019

Air ambulance services are sophisticated and advanced medical services provided in a mobile environment. These services have become an essential component of the modern healthcare system. The medical critical care transport saves lives as it is an effective way to shift or carry critical patients to healthcare facilities. The air ambulance transport services are used in war-torn regions, during natural disasters, outburst of epidemics and road accidents. TechNavio's analysts forecast the Global Air Ambulance market to grow at a CAGR of 9.57 percent over the period 2014-2019. Covered in this Report This report covers the present scenario and the growth prospects of the Global Air Ambulance market for the period 2015-2019. The market size is based on the medical services provided th......
$2500

Global Connected Health M2M Market 2015-2019

Connected health M2M is a remote healthcare service delivery model that functions in an IT ecosystem. It enables the accessing and sharing of healthcare information and the analysis of healthcare data. It provides the management of clinical data, and communication and collaboration among all the stakeholders of the healthcare service ecosystem. Some of the major functions of connected health M2M services are the following: home monitoring, clinical monitoring, telemedicine, first responder connectivity, connected medical environment, clinical remote monitoring, assisted living and clinical trials, and healthcare asset management. TechNavio's analysts forecast the Global Connected Health M2M market to grow at a CAGR of 33.08 percent over the period 2014-2019. Covered in this Report ......
$2500

Global Atrial Fibrillation Market 2015-2019

According to the NHLBI of the NIH in the US, atrial fibrillation is one of the commonest type of arrhythmia. Atrial fibrillation is similar to another type of arrhythmia of the heart, superventricular tachycardia. The chief difference between these two types of arrhythmia is the consistency of the beats. In superventricular tachycardia, the heart beats are regular and at a very fast pace. Patients with atrial fibrillation experience fast and irregular heartbeats. In patients with atrial fibrillation, electrical signals travel rapidly in an uncontrolled way, which causes convulsion, palpitation or contraction in the atria of the heart. Blood is accumulated inside the atrial chambers, instead of flowing to the ventricular chambers. In this case, blood is not pumped into the ventricles fully.......
$2500

Global Equine Healthcare Market 2015-2019

Equine health refers to veterinary services intended to treat horses to enhance their quality of life, increase their lifespan, and develop better quality animal food. Equine diagnostic products, equine therapeutic products, and equine supplement products are the three major product types discussed in this report. Equine diagnostic products help to detect bacteria, antibodies, and viruses; equine therapeutic products include vaccination that helps treat any disease condition; and equine supplement products help in maintaining specific requirement of supplements. TechNavio's analysts forecast the Global Equine Healthcare market to decline at a CAGR of 1.24 percent over the period 2014-2019. Covered in this Report This report covers the present scenario and the growth prospects of t......
$2500

Active Pharmaceutical Ingredients (API) Market in India 2015-2019

Active pharmaceutical ingredients are the active substances that are used in the manufacture of a drug and have a pharmacological effect. They provide health benefits and play a vital role in disease diagnosis, prevention, and treatment. Active pharmaceutical ingredients may be synthesized either chemically or through biotechnological methods. They are used in a wide range of therapeutic areas such as oncology, respiratory disorders, and rheumatoid arthritis. TechNavio's analysts forecast the API market in India to grow at a CAGR of 10.76 percent over the period 2014-2019. Covered in this Report This report covers the present scenario and the growth prospects of the API market in India during the period 2014-2019. To calculate the market size, the report considers the revenue gene......
$3000

Global Anxiety Disorders Market 2015-2019

Anxiety is associated with uneasiness, fearfulness, and tension. Mild anxiety, for example, associated with exams or interview, is normal and triggers 'fight or flight' response. Anxiety without an identifiable cause, anxiety which persists even after the stressful condition is over, and anxiety which is out of proportion of the stressful condition indicates abnormal anxiety. However, severe and persistent anxiety can interfere with everyday activities and might lead to other psychic problems. Anxiety disorder is a mental health disorder characterized by the presence of anxiety. These disorders might occur simultaneously with other disorders such as depression, or along with drug abuse. TechNavio's analysts forecast the Global Anxiety Disorders market to grow at a CAGR of 4.02 percent o......
$2500

Medical Technologies Market in the APAC Region 2015-2019

Medical technology refers to the software solutions, medical devices, imaging, and diagnostic equipment used to ensure good health. The Medical Technologies market in the APAC region covers hospital hardware; technical aids for the disabled; reusable instruments; laboratory equipment; complementary therapy devices; healthcare facility products and adaptations; biologically derived devices; and technologies such as active implantable, anesthetic and respiratory, IVD, dental, electromechanical medical, non-active implantable, ophthalmic and optical, single use, and diagnostic and therapeutic radiation. TechNavio's analysts forecast the Medical Technologies market in the APAC region to grow at a CAGR of 9.87 percent over the period 2014-2019. Covered in this Report This report covers......
$3000

Sickle-cell Anemia Therapeutics Market in the US 2015-2019

Sickle-cell anemia is a disease characterized by the presence of sickle-shaped erythrocytes. While normal erythrocytes have a life span of 120 days, sickle-shaped erythrocytes die within 10 to 20 days. The bone marrow is unable to compensate for the excessive loss of erythrocytes, thereby leading to anemia. It is an inheritable disorder passed on across generations. The prevalence of the sickle-cell gene varies between different ethnic groups and geographical locations. TechNavio's analysts forecast the Sickle-cell Anemia Therapeutics market in the US to grow at a CAGR of 17.10 percent over the period 2014-2019. Covered in this Report This report covers the present scenario and the growth prospects of the Sickle-cell Anemia Therapeutics market in the US for the period 2015-2019. T......
$2500

Global Preclinical Imaging Market 2015-2019

Pre-clinical Imaging is in vivo imaging of small animals, which had been progressively deployed in drug development process. It helps in the visualizing and monitoring of animals for research with respect to tissue, organ, cell (at molecular level), and physiological and environmental changes. One of the main application areas of pre-clinical imaging is early detection of diseases. Currently the most used imaging modalities are optical (fluorescence and bioluminescence), PET, and MRI. In addition, multi-modalities such as PET+CT and SPECT+CT are the most used imaging combinations. In vivo imaging is increasingly used in target identification, compound optimisation and pre-Phase I studies, and in the drug development process. Thus, it bridges the gap between in vitro exploratory and in vivo......
$2500

Epilepsy Market in the US 2015-2019

Epilepsy is a spectrum of brain disorders varying from benign to severe, disabling, and life-threatening symptoms. It is caused by various factors ranging from brain malformations and tumors to meningitis, high-risk pregnancies, and birth trauma. However, when the underlying cause of the disease is unidentified, as in the majority of the cases, it is known as idiopathic epilepsy. Epilepsy is characterized by repeated occurrence of generalized or focal seizures. An imbalance between the inhibitory and excitatory signals of the brain, leading to a sudden onset of excitation, results in seizures. Occurrence of two or more unprovoked seizures is an important criterion to diagnose a person as being epileptic. TechNavio's analysts forecast the Epilepsy market in the US to grow at a CAGR of 4.......
$2500